Job growth returned to the U.S. as it added 49,000 to nonfarm payrolls in January and saw the unemployment rate fall to 6.3%, reports CNBC’s Jeff Cox.
Economists surveyed by Dow Jones were expecting 50,000 additions and for unemployment to be unchanged at 6.7%.
—Melodie Warner
Oxford says AstraZeneca Covid vaccine works against UK variant
A nurse prepares the Oxford-AstraZeneca vaccine at Pontcae Medical Practice on January 4, 2021 in Merthyr Tydfil, Wales.
Matthew Horwood | Getty Images News | Getty Images
AstraZeneca and Oxford University’s Covid-19 vaccine has the same level of efficiency against the Covid variant first discovered in the U.K. as it does with previous variants, CNBC’s Matt Clinch reports.
The variant, known as B.1.1.7, has an unusually high number of mutations and is associated with a more efficient and rapid transmission.
“Data from our trials of the ChAdOx1 vaccine in the United Kingdom indicate that the vaccine not only protects against the original pandemic virus, but also protects against the novel variant, B.1.1.7, which caused the surge in disease from the end of 2020 across the UK,” Andrew Pollard, chief investigator on the Oxford vaccine trial, said in an announcement Friday.
Oxford University earlier this week said a new analysis found a 67% reduction in transmission of Covid after the first dose of the vaccine, based on weekly swabs from volunteers in the U.K. study.
—Melodie Warner
Regeneron’s quarterly profit bolstered by strong Eylea sales
Regeneron Pharmaceuticals’ quarterly profit beat analysts’ estimates as the easing of lockdowns bolstered demand for its flagship eye drug, Reuters reported.
Sales of the macular degeneration drug Eylea were hurt during the height of the pandemic as patients put off visits to doctors’ offices. U.S. sales of the drug rose nearly 10% to $1.34 billion for the fourth quarter, Reuters reported.
Regeneron earned $9.53 per share on an adjusted basis, beating estimates of $8.39 per share, according to Refinitiv IBES data, the wire service said.
—Melodie Warner
Read CNBC’s previous live coverage here: